CN108685800B - Composition for promoting estrogen secretion, emulsion and preparation method thereof - Google Patents
Composition for promoting estrogen secretion, emulsion and preparation method thereof Download PDFInfo
- Publication number
- CN108685800B CN108685800B CN201810884383.1A CN201810884383A CN108685800B CN 108685800 B CN108685800 B CN 108685800B CN 201810884383 A CN201810884383 A CN 201810884383A CN 108685800 B CN108685800 B CN 108685800B
- Authority
- CN
- China
- Prior art keywords
- extract
- breast
- parts
- emulsion
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a breast enlarging composition, breast enlarging emulsion and a preparation method thereof, wherein the breast enlarging composition comprises the following active components in parts by weight: 1-5 parts of austenitic seaweed extract, 0.05-2 parts of chamomile flower extract, 0.05-2 parts of centella extract, 0.01-1 part of licorice root extract, 0.01-1 part of tea extract, 0.05-2 parts of polygonum cuspidatum root extract, 0.05-3 parts of wild pueraria extract, 0.05-2 parts of scutellaria root extract, 0.1-2 parts of total hedyotis root extract, 0.05-2 parts of soybean isoflavone, 0.01-1 part of rosemary leaf extract, 0.5-3 parts of angelica extract, 0.5-3 parts of pomegranate extract and 0.05-1 part of red clover flower extract. The breast enlarging composition and breast enlarging emulsion have good breast enlarging effect, and are safe and free of toxic and side irritation.
Description
Technical Field
The invention relates to the technical field of daily necessities, in particular to a breast enlarging composition, breast enlarging emulsion and a preparation method of the breast enlarging composition.
Background
Breast augmentation, also called breast augmentation or breast augmentation, is an augmentation of female's activities on the breasts to improve personal appeal. With the progress of social economy and civilization and the change of traditional concepts, women have higher pursuit of life quality, and breast dysplasia becomes one of the important problems troubling the lives of women. The breast enhancement method commonly used at present is to perform operation breast enhancement, and silica gel and other products are filled in the breast to achieve the purpose of breast enhancement, but on one hand, the method can leave an incision scar which cannot be disappeared, and on the other hand, the method has strong hysteresis side effect, if effective secondary repair is not performed in the later stage, rebound is easy to occur, and even the rebound is caused, such as: complications such as hematoma, mastoptosis, formation of fibrous capsule, and even breast rupture, and seriously affect the health of the operator.
Disclosure of Invention
Based on the above, there is a need for a safe and effective breast enlarging composition, breast lotion and a preparation method thereof.
The breast enlargement composition comprises the following active components in parts by weight: 1-5 parts of austenitic seaweed extract, 0.05-2 parts of chamomile flower extract, 0.05-2 parts of centella extract, 0.01-1 part of licorice root extract, 0.01-1 part of tea extract, 0.05-2 parts of polygonum cuspidatum root extract, 0.05-3 parts of wild pueraria extract, 0.05-2 parts of scutellaria root extract, 0.1-2 parts of total hedyotis root extract, 0.05-2 parts of soybean isoflavone, 0.01-1 part of rosemary leaf extract, 0.5-3 parts of angelica extract, 0.5-3 parts of pomegranate extract and 0.05-1 part of red clover flower extract.
The breast enlarging composition (estrogen secretion promoting composition) contains rich phytoestrogen, and can bidirectionally regulate the secretion of estrogen (hormone), maintain the balance of estrogen, promote the development of mammary gland, increase the fat content and realize the compaction and the straightening of the breast through the synergistic effect among the components. The breast enlarging composition can inhibit free radicals in vivo, promote metabolism, delay aging, nourish and moisten skin, and enhance firmness, smoothness and softness of breast skin. In addition, each active component of the breast enlargement composition is of a natural plant source, has no toxic or side effect, is safe and effective, and can not generate tolerance even if being used for a long time.
In one embodiment, the extract of the austenitic seaweed is 2 to 4 parts, the extract of the chamomile is 0.1 to 1 part, the extract of the centella asiatica is 0.1 to 1 part, the extract of the licorice root is 0.1 to 0.8 part, the extract of the tea leaf is 0.1 to 0.8 part, the extract of the polygonum cuspidatum root is 0.1 to 1.5 parts, the extract of the pueraria mirifica is 0.1 to 1 part, the extract of the scutellaria baicalensis root is 0.1 to 1 part, the extract of the racemose clubmoss herb is 0.5 to 1 part, the isoflavone is 0.1 to 1 part, the extract of the rosemary leaf is 0.1 to 0.8 part, the extract of the angelica sinensis is 1 to 2 parts, the extract of the pomegranate is 1 to 2 parts, and the extract of the red clover is 0.1 to 0.8 part.
In one embodiment, the pueraria lobata extract comprises a pueraria lobata extract.
The breast enlarging composition is applied to preparing a breast enlarging skin care product.
The breast enlarging composition has the effects of promoting the development of mammary glands, increasing the fat content and realizing the compaction and straightening of breasts, is safe, has no toxic or side effect, and is suitable for preparing breast enlarging skin care products.
A breast enlarging lotion is mainly prepared from the breast enlarging composition, acceptable auxiliary materials in skin care products and water.
The breast enlarging emulsion has the effects of regulating endocrine in two directions, promoting mammary gland development and increasing fat content, and can improve the shape of mammary gland and realize the compaction and the straightening of the chest. The breast enlarging emulsion can delay skin aging, nourish and moisten skin, and enhance the firmness, smoothness and softness of breast skin. In addition, each active component of the breast enlargement emulsion is of a natural plant source, has no toxic or side effect, and is safe and effective.
In one embodiment, the breast enhancement composition accounts for 1-20% of the breast enhancement emulsion by mass.
In one embodiment, the auxiliary material includes: skin conditioning agent, humectant, emollient, stabilizer, emulsifier and antiseptic.
In one embodiment, the breast enlargement emulsion is mainly prepared from the following raw materials in percentage by mass: 3-10% of the breast enlarging composition, 2-8% of a skin conditioner, 5-18% of a humectant, 5-26% of an emollient, 0.2-0.4% of a stabilizer, 3.0-6.0% of an emulsifier, 0.3-0.6% of a preservative and 30-85% of water.
In one embodiment, the skin conditioning agent is selected from: one or more of beta-glucan, dipotassium glycyrrhizinate, sodium polyglutamate, vanillyl butyl ether, menthone glycerol ketal, helichrysum oil and oligopeptide-1;
the humectant is selected from: one or more of glycerol, diglycerol, sodium hyaluronate, propylene glycol, butylene glycol, pentanediol, caprylic glycol, glyceryl caprylate, sorbitol, polyethylene glycol, betaine, ceramide, collagen, urea, chitin derivative, aloe, and seaweed extract;
the emollient is one or more of cyclomethicone, jojoba oil and dimethicone.
In one embodiment, the Helichrysum italicum flower oil is Italian Helichrysum flower oil.
In one embodiment, the skin conditioning agent is a combination of beta-glucan, dipotassium glycyrrhizinate, sodium polyglutamate, vanillyl butyl ether, menthone glycerol ketal, camomile oil, and oligopeptide-1;
the humectant is a combination of sodium hyaluronate, propylene glycol and butanediol;
the emollient is a combination of cyclomethicone, jojoba seed oil and dimethicone;
the emulsifier is cyclopentasiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite;
the preservative is hexanediol/phenoxyethanol/chlorphenesin;
the stabilizing agent is sodium citrate.
In one embodiment, the breast enlargement emulsion is prepared from the following raw materials in percentage by mass: 1 to 10 percent of breast enlargement composition, 2 to 5 percent of beta-glucan, 0.1 to 0.2 percent of dipotassium glycyrrhizinate, 0.1 to 0.2 percent of sodium polyglutamate, 0.01 to 0.1 percent of vanillyl butyl ether, 0.01 to 0.1 percent of menthone glycerol ketal, 0.1 to 0.5 percent of helichrysum oil and 0. 10.0001 to 0.0005 percent of oligopeptide, 0.03-0.1% of sodium hyaluronate, 5-10% of propylene glycol, 1-8% of butanediol, 5-20% of cyclopolydimethylsiloxane, 1-3% of jojoba seed oil, 1-3% of polydimethylsiloxane, 3.0-6.0% of cyclopentadimethylsiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite, 0.3-0.6% of hexanediol/phenoxyethanol/chlorphenesin, 0.2-0.4% of sodium citrate and the balance of water.
By selecting the content of the auxiliary materials and the components, the effect of the breast enlargement emulsion can be improved on one hand, and the breast enlargement emulsion can be ensured to have better physical properties on the other hand.
The preparation method of the breast enlargement emulsion comprises the following steps: dispersing the auxiliary materials in water, adding the breast enlarging composition after uniform dispersion, uniformly stirring, and sterilizing to obtain the breast enlarging emulsion.
The method is simple and easy to implement, can realize production without special instruments, and is suitable for industrial production application.
In the process of preparing the breast-enlarging emulsion, the material adding temperature can be properly increased or the material adding sequence, the stirring speed and the like can be changed as required to promote the dissolution or dispersion of the components.
In one embodiment, the preparation method of the breast enhancement emulsion comprises the following steps:
adding the sodium hyaluronate, the sodium polyglutamate, the propylene glycol, the butanediol, the sodium citrate and the dipotassium glycyrrhizinate into water, and uniformly stirring at 75-80 ℃ to obtain a first component;
uniformly mixing the cyclopolydimethylsiloxane, jojoba seed oil, polydimethylsiloxane, cyclopentadidimethylsiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite at 60-80 ℃ to obtain a second component;
uniformly mixing the second component with the first component and the second component, adding the beta-glucan, the vanillyl butyl ether, the menthone glycerol ketal and the helichrysum oil at the temperature of 50-70 ℃, and uniformly stirring;
cooling to 35-48 ℃, adding the breast enlarging composition, oligopeptide-1 and hexanediol/phenoxyethanol/chlorphenesin, stirring uniformly, and sterilizing to obtain the breast enlarging emulsion.
In the process of preparing the breast-enlarging emulsion, the breast-enlarging composition may be added as a whole, or each active component in the breast-enlarging composition may be added separately in a predetermined ratio, and is not particularly limited herein.
In one embodiment, the preparation method of the breast enhancement emulsion comprises the following steps:
adding the sodium hyaluronate, the sodium polyglutamate, the propylene glycol, the butanediol, the sodium citrate and the dipotassium glycyrrhizinate into water, and uniformly stirring at 75-80 ℃ to obtain a first component;
uniformly mixing the cyclopolydimethylsiloxane, jojoba seed oil, polydimethylsiloxane, cyclopentadidimethylsiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite at 60-80 ℃ to obtain a second component;
uniformly mixing the second component with the first component and the second component, adding the beta-glucan, the austenitic seaweed extract, the vanillyl butyl ether, the menthone glycerol ketal and the helichrysum oil at the temperature of 50-70 ℃, and uniformly stirring;
cooling to 35-48 ℃, adding the chamomile flower extract, the centella asiatica extract, the licorice root extract, the tea leaf extract, the polygonum cuspidatum root extract, the pueraria lobata extract, the scutellaria baicalensis root extract, the hedera helix root extract, the soybean isoflavone, the rosemary leaf extract, the angelica sinensis extract, the pomegranate extract, the red clover flower extract, oligopeptide-1 and hexanediol/phenoxyethanol/chlorphenesin, stirring uniformly, and sterilizing to obtain the breast enlargement emulsion.
Detailed Description
In order that the invention may be more fully understood, a more particular description of the invention will now be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
It should be noted that the reagent or apparatus of the present invention is not specified as a specific source, and is a conventional reagent or apparatus purchased in the market.
Cyclopenta dimethyl silicone/PEG-10 dimethyl silicone/distearyl dimethyl ammonium hectorite in the present invention means a material consisting of cyclopenta dimethyl silicone, PEG-10 dimethyl silicone and distearyl dimethyl ammonium hectorite, for example: nikkomulse WO (Japanese Sun light Co., Ltd.)
Hexylene glycol/phenoxyethanol/chlorphenesin refers to a substance consisting of hexylene glycol, phenoxyethanol, and chlorphenesin, for example: microcare PHCH (THOR group, UK).
Example 1
Composition of the breast augmentation composition of this example: as in table 1.
The breast enlargement emulsion is prepared from the following raw materials in percentage by mass: 20% of breast augmentation composition, 3% of beta-glucan, 0.15% of dipotassium glycyrrhizinate, 0.15% of sodium polyglutamate, 0.05% of vanillyl butyl ether, 0.05% of menthone glycerol ketal, 0.3% of camomile oil, oligopeptide-10.0003%, 0.08% of sodium hyaluronate, 7% of propylene glycol, 4% of butanediol, 10% of cyclopolydimethylsiloxane, 2% of jojoba seed oil, 2% of polydimethylsiloxane, 5% of cyclopentadimethylsiloxane/PEG-10 polydimethylsiloxane/distearyldimethylammonium hectorite, 0.4% of hexanediol/phenoxyethanol/chlorphenesin, 0.3% of sodium citrate and the balance of water.
The preparation method of the breast enlargement emulsion comprises the following steps:
1) adding deionized water into an emulsifying pot, wetting sodium hyaluronate and sodium polyglutamate with propylene glycol, adding into the emulsifying pot, stirring, sequentially adding sodium citrate and dipotassium glycyrrhizinate, heating to 75-80 deg.C, and keeping the temperature for 10 min.
2) Adding cyclomethicone, jojoba seed oil, dimethicone, cyclopentadimethicone/PEG-10 dimethicone/disteardimonium hectorite (Nikkomule WO) into oil phase pan, heating and heating to 70 deg.C;
3) pumping the oil phase materials into an emulsifying pot, starting high-speed homogenization (3000 r/min), homogenizing for 8 minutes, and uniformly stirring; and starting to cool.
4) Cooling to 60 deg.C, adding beta-dextran, Sargassum Australicum extract, vanillyl butyl ether, menthone glycerol ketal, and Parthenia italica flower oil, and homogenizing at low speed for 5 min.
5) Cooling, cooling to 45 deg.C, adding flos Matricariae Chamomillae extract, herba Centellae extract, Glycyrrhrizae radix extract, folium Camelliae sinensis extract, rhizoma Polygoni Cuspidati extract, radix Puerariae Lobatae extract, Scutellariae radix extract, radix Helianthi extract, soybean isoflavone, herba Rosmarini officinalis leaf extract, radix Angelicae sinensis extract, fructus Punicae Granati extract, flos Trifolii Pratentis, oligopeptide-1, and hexanediol/phenoxyethanol/chlorphenesin (Microcare PHCH), and stirring.
6) And (4) cooling to 38 ℃, checking to be qualified, and filling to obtain the breast enhancement emulsion of the embodiment 1.
Table 1: compositions and contents (parts by weight) of breast enlarging compositions of examples 1 to 4
Example 2
Composition of the breast augmentation composition of this example: as in table 1.
The breast enlargement emulsion is prepared from the following raw materials in percentage by mass: 15% of breast enlargement composition, 2% of beta-glucan, 0.2% of dipotassium glycyrrhizinate, 0.2% of sodium polyglutamate, 0.07% of vanillyl butyl ether, 0.08% of menthone glycerol ketal, 0.4% of camomile oil, 0.1% of oligopeptide-10.0005%, 0.1% of sodium hyaluronate, 8% of propylene glycol, 6% of butanediol, 13% of cyclopolydimethylsiloxane, 2.5% of jojoba seed oil, 2.5% of polydimethylsiloxane, 5% of cyclopentadidimethylsiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite, 0.4% of hexanediol/phenoxyethanol/chlorphenesin, 0.3% of sodium citrate and the balance of water.
The breast-enlarging lotion was prepared in the same manner as in example 1.
Example 3
Composition of the breast augmentation composition of this example: as in table 1.
The breast enlargement emulsion is prepared from the following raw materials in percentage by mass: 10% of breast enlargement composition, 5% of beta-glucan, 0.2% of dipotassium glycyrrhizinate, 0.2% of sodium polyglutamate, 0.1% of vanillyl butyl ether, 0.08% of menthone glycerol ketal, 0.4% of camomile oil, 0.1% of oligopeptide-10.0005%, 0.1% of sodium hyaluronate, 8% of propylene glycol, 2% of butanediol, 14% of cyclopolydimethylsiloxane, 3% of jojoba seed oil, 3% of polydimethylsiloxane, 5% of cyclopentadidimethylsiloxane/PEG-10 polydimethylsiloxane/distearyldimethylammonium hectorite, 0.4% of hexanediol/phenoxyethanol/chlorphenesin, 0.3% of sodium citrate and the balance of water.
The breast-enlarging lotion was prepared in the same manner as in example 1.
Example 4
Composition of the breast augmentation composition of this example: as in table 1.
The breast enlargement emulsion is prepared from the following raw materials in percentage by mass: 3% of breast enlargement composition, 2% of beta-glucan, 0.1% of dipotassium glycyrrhizinate, 0.1% of sodium polyglutamate, 0.05% of vanillyl butyl ether, 0.08% of menthone glycerol ketal, 0.4% of camomile oil, 0.1% of oligopeptide-10.0005%, 0.1% of sodium hyaluronate, 5% of propylene glycol, 5% of butanediol, 16% of cyclopolydimethylsiloxane, 2% of jojoba seed oil, 2% of polydimethylsiloxane, 4% of cyclopentadidimethylsiloxane/PEG-10 polydimethylsiloxane/distearyldimethylammonium hectorite, 0.3% of hexanediol/phenoxyethanol/chlorphenesin, 0.2% of sodium citrate and the balance of water.
The breast-enlarging lotion was prepared in the same manner as in example 1.
Comparative example 1
Breast augmentation composition of this comparative example: as in table 2.
The breast enhancement emulsion of this comparative example was substantially the same as example 2, except that the breast enhancement composition was different and the breast enhancement composition of this comparative example did not contain the extract of the seaweeds austenitic.
The preparation method of the breast enlargement emulsion of the comparative example comprises the following steps: the same as in example 1.
Table 2: breast enlarging composition of comparative examples 1 to 4 and content thereof (parts by weight)
Comparative example 2
Breast augmentation composition of this comparative example: as in table 2.
The breast enhancement emulsion of this comparative example was substantially the same as example 2 except that the breast enhancement composition was different and did not contain chamomile flower extract, centella asiatica extract, licorice root extract and tea leaf extract.
The preparation method of the breast enlargement emulsion of the comparative example comprises the following steps: the same as in example 1.
Comparative example 3
Breast augmentation composition of this comparative example: as in table 2.
The breast enhancement emulsion of this comparative example was substantially the same as that of example 2, except that the breast enhancement composition was different and did not contain the polygonum cuspidatum root extract, the pueraria lobata extract, the scutellaria baicalensis root extract, and the cimicifuga racemosa root extract.
The preparation method of the breast enlargement emulsion of the comparative example comprises the following steps: the same as in example 1.
Comparative example 4
Breast augmentation composition of this comparative example: as in table 2.
The breast enhancement emulsion of this comparative example was substantially the same as example 2 except that the breast enhancement composition was different and the breast enhancement composition of this comparative example did not contain soy isoflavones, rosemary leaf extract, angelica extract, and pomegranate extract.
The preparation method of the breast enlargement emulsion of the comparative example comprises the following steps: the same as in example 1.
Clinical experiments
First, subject screening
Inclusion criteria were: 80 volunteers, female 18-45 years old; the breast-enlarging emulsions of examples 1 to 4 and comparative examples 1 to 4 described above were tested by randomly dividing the volunteers into 8 groups of 10 individuals (group 1 using the emulsion of example 1, group 2 using the emulsion of example 2, group 3 using the emulsion of example 3, group 4 using the emulsion of example 4, group 5 using the emulsion of comparative example 1, group 6 using the emulsion of comparative example 2, group 7 using the emulsion of comparative example 3, group 8 using the emulsion of comparative example 4).
And (3) inclusion standard: female with low sexual hormone level or mammary dysplasia (including small breast, loose and drooping breast), non-endocrine diseases, mammary gland diseases and gynecological diseases, non-pregnant period or lactation period.
Second, test standard
The product is applied to breast for 2 times per day for three months, and is forbidden to eat contraceptive, hormone medicine and weight reducing medicine 1 month before test and during test, and is forbidden to use similar product 1 month before test and during test.
Third, clinical test
(1) Breast tissue thickness, breast subcutaneous fat thickness test
The thickness of subcutaneous fat before and after the volunteer used the product was measured using a color doppler ultrasound instrument, and the test values of all persons in each group were collected and averaged, and the test results are shown in table 3 below.
Table 3: test results of breast tissue thickness and breast subcutaneous fat thickness
*p＜0.01，#p＜0.01
(2) Breast volume testing
The volunteer stands, the upper limbs naturally droop, the distances of the nipple-the inner side point (MR), the outer side point (LR) and the lowest point (IR) of the crinkled wall and the distance (MP) of the most prominent point of the breast-the chest wall are tested, and then the formula is calculated according to the arbor group: breast volume of 1/3 pi × MP2X (MR + LR + IR-MP) calculating the volume of the volunteer's breast; the values for all people in each group were averaged and the results are shown in Table 4 below.
Table 4: breast volume measurement
(3) Breast ptosis test
During testing, the volunteer stands upright naturally, the two upper limbs droop naturally, the drooping degree of the breast is tested by taking the nipple and the skin reverse fold line under the breast as reference, and the evaluation standard is as follows:
and (3) sagging at I degree: the inverted fold line of the nipple and the skin under the breast is equal;
and (2) sagging at II degrees: the nipple is lower than the nipple and the reverse fold line of the skin under the breast;
and III degree droop: the nipple is located at the lowest part of the breast;
the test results are shown in Table 5 below
Table 5: breast ptosis measurement
(4) Breast skin moisture test
Selecting skin near nipples, testing the skin at the temperature of 25 +/-2 ℃ and the humidity of 50 +/-5 percent, cleaning the tested parts before testing, using a Corneometer CM825 to measure the skin near the nipples after sitting for 1h, summarizing the test values of all people in each group, taking the average value, representing all the test data as the mean +/-standard deviation, and obtaining the measurement results shown in the following table 6.
Table 6: measuring result of breast skin moistening degree
Fourth, results and analysis
As can be seen from table 3, the test groups (group 1 to group 4) using the products of examples 1 to 4 had both significant increases in the thickness of the subcutaneous fat in the breast tissue and the breast, and the test groups (group 5 to group 6) using the products of comparative examples 1 to 4 had both significant increases in the thickness of the subcutaneous fat in the breast tissue and the breast, but the magnitude of the increase was significantly smaller than that of the test group using the products of examples 1 to 4.
As can be seen from table 4, the breast volumes of the test groups (group 1 to group 4) using the products of examples 1 to 4 were all significantly increased, and the breast volumes of the test groups (group 5 to group 6) using the products of comparative examples 1 to 4 were increased, but the increase was significantly smaller than that of the test groups using the products of examples 1 to 4.
As can be seen from table 5, the test groups (group 1 to group 4) using the products of examples 1 to 4 had a significant improvement in breast ptosis, and the test groups (group 5 to group 6) using the products of comparative examples 1 to 4 had a weak improvement in breast ptosis.
As can be seen from Table 6, the breast-enlarging lotions of examples 1 to 4 and comparative examples 1 to 4 all had skin-moisturizing effects.
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (8)
1. A breast enlarging emulsion is characterized in that the breast enlarging emulsion is mainly prepared from a breast enlarging composition, acceptable auxiliary materials in skin care products and water; the breast enlargement composition comprises the following active components in parts by weight: 1-5 parts of austenitic seaweed extract, 0.05-2 parts of chamomile flower extract, 0.05-2 parts of centella extract, 0.01-1 part of licorice root extract, 0.01-1 part of tea extract, 0.05-2 parts of polygonum cuspidatum root extract, 0.05-3 parts of wild pueraria extract, 0.05-2 parts of scutellaria root extract, 0.1-2 parts of total hedyotis root extract, 0.05-2 parts of soybean isoflavone, 0.01-1 part of rosemary leaf extract, 0.5-3 parts of angelica extract, 0.5-3 parts of pomegranate extract and 0.05-1 part of red clover flower extract.
2. The breast enhancement emulsion of claim 1 wherein the extract of the austenitic seaweed is 2-4 parts, the extract of the chamomile flower is 0.1-1 part, the extract of the centella asiatica is 0.1-1 part, the extract of the licorice root is 0.1-0.8 part, the extract of the tea leaf is 0.1-0.8 part, the extract of the polygonum cuspidatum root is 0.1-1.5 parts, the extract of the pueraria lobata is 0.1-1 part, the extract of the scutellaria baicalensis root is 0.1-1 part, the extract of the hibiscus racemosus root is 0.5-1 part, the isoflavone is 0.1-1 part, the extract of the rosemary leaf is 0.1-0.8 part, the extract of the angelica sinensis is 1-2 parts, the extract of the pomegranate is 1-2 parts, and the extract of the flower of the red clover is 0.1-0.8 part.
3. The breast enhancement emulsion of claim 1 wherein the breast enhancement composition is present in the emulsion at a level of from 1% to 20% by weight.
4. The breast enhancement emulsion as claimed in claim 1, which is prepared from the following raw materials in percentage by mass: 3-10% of the breast enlarging composition, 2-8% of a skin conditioner, 5-18% of a humectant, 5-26% of an emollient, 0.2-0.4% of a stabilizer, 3.0-6.0% of an emulsifier, 0.3-0.6% of a preservative and 30-85% of water.
5. The breast enhancement emulsion of claim 4,
the skin conditioning agent is selected from: one or more of beta-glucan, dipotassium glycyrrhizinate, sodium polyglutamate, vanillyl butyl ether, menthone glycerol ketal, helichrysum oil and oligopeptide-1;
the humectant is selected from: one or more of glycerol, diglycerol, sodium hyaluronate, propylene glycol, butylene glycol, pentanediol, caprylic glycol, glyceryl caprylate, sorbitol, polyethylene glycol, betaine, ceramide, collagen, urea, aloe vera, and seaweed extract;
the emollient is one or more of cyclomethicone, jojoba oil and dimethicone.
6. The breast enhancement emulsion of claim 5,
the skin conditioner is a combination of beta-glucan, dipotassium glycyrrhizinate, sodium polyglutamate, vanillyl butyl ether, menthone glycerol ketal, camomile oil and oligopeptide-1;
the humectant is a combination of sodium hyaluronate, propylene glycol and butanediol;
the emollient is a combination of cyclomethicone, jojoba seed oil and dimethicone;
the emulsifier is cyclopentasiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite;
the preservative is hexanediol/phenoxyethanol/chlorphenesin;
the stabilizing agent is sodium citrate.
7. The breast enhancement emulsion as claimed in claim 6, which is prepared from the following raw materials in percentage by mass:
3-10% of breast enlargement composition, 2-5% of beta-glucan, 0.1-0.2% of dipotassium glycyrrhizinate, 0.1-0.2% of sodium polyglutamate, 0.01-0.1% of vanillyl butyl ether, 0.01-0.1% of menthone glycerol ketal, 0.1-0.5% of camomile oil, 10.0001-0.0005% of oligopeptide, 0.03-0.1% of sodium hyaluronate, 5-10% of propylene glycol, 1-8% of butanediol, 5-20% of cyclopolydimethylsiloxane, 1-3% of jojoba seed oil, 1-3% of polydimethylsiloxane, 3.0-6.0% of cyclopentadidimethylsiloxane/PEG-10 polydimethylsiloxane/disteardimonium hectorite, 0.3-0.6% of hexanediol/phenoxyethanol/chlorphenesin, 0.2 to 0.4 percent of sodium citrate and the balance of water.
8. A process for the preparation of a breast enhancing emulsion as claimed in any one of claims 1 to 7 comprising the steps of: dispersing the auxiliary materials in water, adding the breast enlarging composition after uniform dispersion, uniformly stirring, and sterilizing to obtain the breast enlarging emulsion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810884383.1A CN108685800B (en) | 2018-08-06 | 2018-08-06 | Composition for promoting estrogen secretion, emulsion and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810884383.1A CN108685800B (en) | 2018-08-06 | 2018-08-06 | Composition for promoting estrogen secretion, emulsion and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108685800A CN108685800A (en) | 2018-10-23 |
| CN108685800B true CN108685800B (en) | 2022-03-25 |
Family
ID=63841169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810884383.1A Active CN108685800B (en) | 2018-08-06 | 2018-08-06 | Composition for promoting estrogen secretion, emulsion and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108685800B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109091405A (en) * | 2018-10-26 | 2018-12-28 | 广州市白云区大荣精细化工有限公司 | A kind of warm skin care item and preparation method thereof |
| CN109464338A (en) * | 2018-12-23 | 2019-03-15 | 广州航美化妆品有限公司 | A kind of bust treatment Essence |
| CN109700734A (en) * | 2018-12-25 | 2019-05-03 | 澳宝化妆品（惠州）有限公司 | The strong newborn composition of one kind compound breast-rounding containing plant and its application |
| CN110339136B (en) * | 2019-08-23 | 2022-09-09 | 杭州千岛湖蓝色天使实业有限公司 | Charming composition and preparation method thereof |
| CN115998657A (en) * | 2023-03-23 | 2023-04-25 | 广州华厦生物制药有限公司 | Anti-hair loss essence and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105997649A (en) * | 2016-06-17 | 2016-10-12 | 广州市彩枫行贸易有限公司 | Breast enlarging composition |
| CN106492104A (en) * | 2016-12-13 | 2017-03-15 | 深圳市月之韵实业有限公司 | A kind of breast enlargement compositionss and preparation method thereof |
| CN108078831A (en) * | 2017-11-28 | 2018-05-29 | 江西登云健康美业互联有限公司 | A kind of multi-functional skin Essence and preparation method thereof |
| CN108096389A (en) * | 2017-11-24 | 2018-06-01 | 广州绿人生物科技有限公司 | A kind of U.S.'s chest composition and its preparation method and application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100787963B1 (en) * | 2005-12-30 | 2007-12-27 | (주)필리엠에스피 | Pack for breast containing extract of Pueraria mirifica |
-
2018
- 2018-08-06 CN CN201810884383.1A patent/CN108685800B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105997649A (en) * | 2016-06-17 | 2016-10-12 | 广州市彩枫行贸易有限公司 | Breast enlarging composition |
| CN106492104A (en) * | 2016-12-13 | 2017-03-15 | 深圳市月之韵实业有限公司 | A kind of breast enlargement compositionss and preparation method thereof |
| CN108096389A (en) * | 2017-11-24 | 2018-06-01 | 广州绿人生物科技有限公司 | A kind of U.S.'s chest composition and its preparation method and application |
| CN108078831A (en) * | 2017-11-28 | 2018-05-29 | 江西登云健康美业互联有限公司 | A kind of multi-functional skin Essence and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108685800A (en) | 2018-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108685800B (en) | Composition for promoting estrogen secretion, emulsion and preparation method thereof | |
| CN101889966B (en) | Preparation method of tea oil anti-cracking cream composition and product thereof | |
| CN101084870A (en) | Emulsifying salt type traditional Chinese herbs emulsion used for washing and caring hair and preparation method thereof | |
| CN105943432A (en) | Peach gum moisturizing gel mask and preparation method thereof | |
| CN108272707A (en) | A kind of Chinese herbal medicine hair conditioner and preparation method thereof | |
| CN106619337A (en) | Crowfoot crack resistant cream for infants and a preparing method thereof | |
| CN108969446A (en) | It is a kind of enhance skin barrier function infant prevent chapped skin care compositions and preparation method thereof | |
| CN106265478A (en) | A kind of skin care compositions with breast enlargement effect and application thereof | |
| KR20090005479A (en) | Composition for promoting hair growth | |
| CN102614103A (en) | Middle and old-aged nourishing and wrinkle-resisting cream and preparation method thereof | |
| CN107233245A (en) | A kind of massage cream and preparation method thereof | |
| CN110974771A (en) | Scalp care composition and application thereof | |
| CN106606451A (en) | Moisturizing and repairing hair conditioner | |
| CN108785163A (en) | Chest enlarge emulsifiable paste and preparation method thereof and application method | |
| CN107669617A (en) | The tender skin cosmetics of natural anti-wrinkle | |
| CN107375069A (en) | A kind of Anti-hair loss deoils herbal essences shampoo | |
| CN111434332A (en) | Nourishing and repairing emulsion and preparation method thereof | |
| CN104523530A (en) | Anti-aging facial mask and preparation method thereof | |
| CN109363977A (en) | Clear CC frost of a kind of moist water profit and preparation method thereof | |
| CN112516025A (en) | Plant extract composition cream with transdermal absorption effect and preparation method thereof | |
| CN108392455A (en) | Face cream and preparation method thereof containing dendrobium candidum extract | |
| CN110721101A (en) | Self-prepared two-component essence cream and preparation method thereof | |
| CN110960436A (en) | Skin care composition, eye cream and preparation method thereof | |
| CN106580821A (en) | Composition for alleviating skin allergy and redness and application thereof in infant body lotions | |
| CN105997640A (en) | Chest enlarging skin care product containing plant ingredients and preparation method of chest enlarging skin care product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |